메뉴 건너뛰기
Journal of Virology
Volumn 88, Issue 14, 2014, Pages 8028-8044
Activation and repression of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids
Author keywords

[No Author keywords available]
Indexed keywords

4 PHENYLBUTYRIC ACID; BUTYRIC ACID; IMMEDIATE EARLY PROTEIN BZLF1; ISOBUTYRIC ACID; MEDIUM CHAIN FATTY ACID; SHORT CHAIN FATTY ACID; VALPROIC ACID;
EID: 84904667890     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00722-14     Document Type: Article
Times cited : (53)
References (90)
  • 2
    • 0023503201 scopus 로고
    • Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency
    • Countryman J, Jenson H, Seibl R, Wolf H, Miller G. 1987. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J. Virol. 61:3672-3679.
    • (1987) J. Virol. , vol.61 , pp. 3672-3679
    • Countryman, J.1    Jenson, H.2    Seibl, R.3    Wolf, H.4    Miller, G.5
  • 3
    • 1642457437 scopus 로고
    • Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA
    • Countryman J, Miller G. 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. U. S. A. 82:4085-4089. http://dx.doi.org/10.1073/pnas.82.12.4085.
    • (1985) Proc. Natl. Acad. Sci. U. S. A. , vol.82 , pp. 4085-4089
    • Countryman, J.1    Miller, G.2
  • 4
    • 0023889721 scopus 로고
    • A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen
    • Hardwick JM, Lieberman PM, Hayward SD. 1988. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62:2274-2284.
    • (1988) J. Virol. , vol.62 , pp. 2274-2284
    • Hardwick, J.M.1    Lieberman, P.M.2    Hayward, S.D.3
  • 5
    • 0031694397 scopus 로고    scopus 로고
    • The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes
    • Ragoczy T, Heston L, Miller G. 1998. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol. 72:7978-7984.
    • (1998) J. Virol. , vol.72 , pp. 7978-7984
    • Ragoczy, T.1    Heston, L.2    Miller, G.3
  • 6
    • 0029830047 scopus 로고    scopus 로고
    • Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism
    • Zalani S, Holley-Guthrie E, Kenney S. 1996. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. U. S. A. 93:9194-9199. http://dx.doi.org/10.1073/pnas.93.17.9194.
    • (1996) Proc. Natl. Acad. Sci. U. S. A. , vol.93 , pp. 9194-9199
    • Zalani, S.1    Holley-Guthrie, E.2    Kenney, S.3
  • 7
    • 0032167919 scopus 로고    scopus 로고
    • A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus
    • Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U. S. A. 95:10866-10871. http://dx.doi.org/10.1073/pnas.95.18.10866.
    • (1998) Proc. Natl. Acad. Sci. U. S. A. , vol.95 , pp. 10866-10871
    • Sun, R.1    Lin, S.F.2    Gradoville, L.3    Yuan, Y.4    Zhu, F.5    Miller, G.6
  • 8
    • 0032567394 scopus 로고    scopus 로고
    • Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein
    • Lukac DM, Renne R, Kirshner JR, Ganem D. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304-312. http://dx.doi.org/10.1006/viro.1998.9486.
    • (1998) Virology , vol.252 , pp. 304-312
    • Lukac, D.M.1    Renne, R.2    Kirshner, J.R.3    Ganem, D.4
  • 9
    • 0034083471 scopus 로고    scopus 로고
    • Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line
    • Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, Metroka C, Miller G. 2000. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 74:6207-6212. http://dx.doi.org/10.1128/JVI.74.13.6207-6212.2000.
    • (2000) J. Virol. , vol.74 , pp. 6207-6212
    • Gradoville, L.1    Gerlach, J.2    Grogan, E.3    Shedd, D.4    Nikiforow, S.5    Metroka, C.6    Miller, G.7
  • 10
    • 33845427459 scopus 로고    scopus 로고
    • Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator
    • Wang Y, Tang Q, Maul GG, Yuan Y. 2006. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J. Virol. 80:12171-12186. http://dx.doi.org/10.1128/JVI.00990-06.
    • (2006) J. Virol. , vol.80 , pp. 12171-12186
    • Wang, Y.1    Tang, Q.2    Maul, G.G.3    Yuan, Y.4
  • 11
    • 0019410144 scopus 로고
    • Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines
    • Ben-Sasson SA, Klein G. 1981. Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. Int. J. Cancer 28:131-135. http://dx.doi.org/10.1002/ijc.2910280204.
    • (1981) Int. J. Cancer , vol.28 , pp. 131-135
    • Ben-Sasson, S.A.1    Klein, G.2
  • 12
    • 0025837283 scopus 로고
    • Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumorpromoting phorbol esters requires active protein kinase C
    • Davies AH, Grand RJ, Evans FJ, Rickinson AB. 1991. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumorpromoting phorbol esters requires active protein kinase C. J. Virol. 65: 6838-6844.
    • (1991) J. Virol. , vol.65 , pp. 6838-6844
    • Davies, A.H.1    Grand, R.J.2    Evans, F.J.3    Rickinson, A.B.4
  • 13
    • 0018384722 scopus 로고
    • Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate
    • Luka J, Kallin B, Klein G. 1979. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228-231. http://dx.doi.org/10.1016/0042-6822(79)90455-0.
    • (1979) Virology , vol.94 , pp. 228-231
    • Luka, J.1    Kallin, B.2    Klein, G.3
  • 14
    • 0021351866 scopus 로고
    • Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines
    • Takada K. 1984. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32. http://dx.doi.org/10.1002/ijc.2910330106.
    • (1984) Int. J. Cancer , vol.33 , pp. 27-32
    • Takada, K.1
  • 15
    • 0017876123 scopus 로고
    • Persisting oncogenic herpesvirus induced by the tumour promotor TPA
    • zur Hausen H, O'Neill FJ, Freese UK, Hecker E. 1978. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272: 373-375. http://dx.doi.org/10.1038/272373a0.
    • (1978) Nature , vol.272 , pp. 373-375
    • Zur Hausen, H.1    O'Neill, F.J.2    Freese, U.K.3    Hecker, E.4
  • 16
    • 0019176585 scopus 로고
    • Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus
    • Saemundsen AK, Kallin B, Klein G. 1980. Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus. Virology 107:557-561. http://dx.doi.org/10.1016/0042-6822(80)90326-8.
    • (1980) Virology , vol.107 , pp. 557-561
    • Saemundsen, A.K.1    Kallin, B.2    Klein, G.3
  • 17
    • 34548147218 scopus 로고    scopus 로고
    • De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists
    • Ye J, Gradoville L, Daigle D, Miller G. 2007. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. J. Virol. 81:9279-9291. http://dx.doi.org/10.1128/JVI.00982-07.
    • (2007) J. Virol. , vol.81 , pp. 9279-9291
    • Ye, J.1    Gradoville, L.2    Daigle, D.3    Miller, G.4
  • 18
    • 13744256651 scopus 로고    scopus 로고
    • An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate
    • Ye J, Shedd D, Miller G. 2005. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J. Virol. 79:1397-1408. http://dx.doi.org/10.1128/JVI.79.3.1397-1408.2005.
    • (2005) J. Virol. , vol.79 , pp. 1397-1408
    • Ye, J.1    Shedd, D.2    Miller, G.3
  • 19
    • 10544237674 scopus 로고    scopus 로고
    • Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells
    • Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. 1997. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71:314-324.
    • (1997) J. Virol. , vol.71 , pp. 314-324
    • Miller, G.1    Heston, L.2    Grogan, E.3    Gradoville, L.4    Rigsby, M.5    Sun, R.6    Shedd, D.7    Kushnaryov, V.M.8    Grossberg, S.9    Chang, Y.10
  • 20
    • 0029876473 scopus 로고    scopus 로고
    • Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
    • Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346. http://dx.doi.org /10.1038/nm0396-342.
    • (1996) Nat. Med. , vol.2 , pp. 342-346
    • Renne, R.1    Zhong, W.2    Herndier, B.3    McGrath, M.4    Abbey, N.5    Kedes, D.6    Ganem, D.7
  • 21
    • 1842431602 scopus 로고    scopus 로고
    • Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway
    • Wang SE, Wu FY, Chen H, Shamay M, Zheng Q, Hayward GS. 2004. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 78:4248-4267. http://dx.doi.org/10.1128/JVI.78.8.4248-4267.2004.
    • (2004) J. Virol. , vol.78 , pp. 4248-4267
    • Wang, S.E.1    Wu, F.Y.2    Chen, H.3    Shamay, M.4    Zheng, Q.5    Hayward, G.S.6
  • 22
    • 0036091859 scopus 로고    scopus 로고
    • Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle
    • Gradoville L, Kwa D, El-Guindy A, Miller G. 2002. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. J. Virol. 76:5612-5626. http://dx.doi.org/10.1128/JVI.76.11.5612-5626.2002.
    • (2002) J. Virol. , vol.76 , pp. 5612-5626
    • Gradoville, L.1    Kwa, D.2    El-Guindy, A.3    Miller, G.4
  • 23
    • 70349748580 scopus 로고    scopus 로고
    • Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus
    • Countryman J, Gradoville L, Bhaduri-McIntosh S, Ye J, Heston L, Himmelfarb S, Shedd D, Miller G. 2009. Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus. J. Virol. 83:10694-10709. http://dx.doi.org/10.1128 /JVI.01172-09.
    • (2009) J. Virol. , vol.83 , pp. 10694-10709
    • Countryman, J.1    Gradoville, L.2    Bhaduri-McIntosh, S.3    Ye, J.4    Heston, L.5    Himmelfarb, S.6    Shedd, D.7    Miller, G.8
  • 24
    • 0026335966 scopus 로고
    • Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation
    • Mellinghoff I, Daibata M, Humphreys RE, Mulder C, Takada K, Sairenji T. 1991. Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation. Virology 185:922-928. http://dx.doi.org/10.1016/0042-6822(91)90574-U.
    • (1991) Virology , vol.185 , pp. 922-928
    • Mellinghoff, I.1    Daibata, M.2    Humphreys, R.E.3    Mulder, C.4    Takada, K.5    Sairenji, T.6
  • 25
    • 0025726282 scopus 로고
    • An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA
    • Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156. http://dx.doi.org/10.1007/BF00571929.
    • (1991) Virus Genes , vol.5 , pp. 147-156
    • Takada, K.1    Horinouchi, K.2    Ono, Y.3    Aya, T.4    Osato, T.5    Takahashi, M.6    Hayasaka, S.7
  • 26
    • 33746916100 scopus 로고    scopus 로고
    • Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBVseropositive individuals
    • Bhaduri-McIntosh S, Miller G. 2006. Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBVseropositive individuals. J. Virol. Methods 137:103-114. http://dx.doi.org /10.1016/j.jviromet.2006.06.006.
    • (2006) J. Virol. Methods , vol.137 , pp. 103-114
    • Bhaduri-McIntosh, S.1    Miller, G.2
  • 27
    • 73849116103 scopus 로고    scopus 로고
    • Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors
    • Daigle D, Megyola C, El-Guindy A, Gradoville L, Tuck D, Miller G, Bhaduri-McIntosh S. 2010. Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors. J. Virol. 84:993-1004. http://dx.doi.org/10.1128/JVI.01745-09.
    • (2010) J. Virol. , vol.84 , pp. 993-1004
    • Daigle, D.1    Megyola, C.2    El-Guindy, A.3    Gradoville, L.4    Tuck, D.5    Miller, G.6    Bhaduri-McIntosh, S.7
  • 28
    • 43249126604 scopus 로고    scopus 로고
    • Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virusinfected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors
    • Countryman JK, Gradoville L, Miller G. 2008. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virusinfected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J. Virol. 82:4706-4719. http://dx.doi.org/10.1128 /JVI.00116-08.
    • (2008) J. Virol. , vol.82 , pp. 4706-4719
    • Countryman, J.K.1    Gradoville, L.2    Miller, G.3
  • 29
    • 79956067296 scopus 로고    scopus 로고
    • Valproic acid antagonizes the capacity of other HDAC inhibitors to activate the Epstein-Barr virus lytic cycle
    • Daigle D, Gradoville L, Tuck D, Schultz V, Wong'ondu R, Ye J, Gorres K, Miller G. 2011. Valproic acid antagonizes the capacity of other HDAC inhibitors to activate the Epstein-Barr virus lytic cycle. J. Virol. 85:5628-5643. http://dx.doi.org/10.1128/JVI.02659-10.
    • (2011) J. Virol. , vol.85 , pp. 5628-5643
    • Daigle, D.1    Gradoville, L.2    Tuck, D.3    Schultz, V.4    Wong'ondu, R.5    Ye, J.6    Gorres, K.7    Miller, G.8
  • 30
    • 0034025524 scopus 로고    scopus 로고
    • Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells
    • Shaw RN, Arbiser JL, Offermann MK. 2000. Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS 14:899-902. http://dx.doi.org/10.1097/00002030-200005050-00021.
    • (2000) AIDS , vol.14 , pp. 899-902
    • Shaw, R.N.1    Arbiser, J.L.2    Offermann, M.K.3
  • 31
    • 24044496609 scopus 로고    scopus 로고
    • Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma
    • Klass CM, Offermann MK. 2005. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma. Curr. Opin. Oncol. 17:447-455. http://dx.doi.org/10.1097/01.cco.0000172823.01190.6c.
    • (2005) Curr. Opin. Oncol. , vol.17 , pp. 447-455
    • Klass, C.M.1    Offermann, M.K.2
  • 32
    • 0023276469 scopus 로고
    • Short chain fatty acids in human large intestine, portal, hepatic and venous blood
    • Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221-1227. http://dx.doi.org/10.1136/gut.28.10.1221.
    • (1987) Gut , vol.28 , pp. 1221-1227
    • Cummings, J.H.1    Pomare, E.W.2    Branch, W.J.3    Naylor, C.P.4    Macfarlane, G.T.5
  • 33
    • 80052712639 scopus 로고    scopus 로고
    • Clinical and experimental applications of sodium phenylbutyrate
    • Iannitti T, Palmieri B. 2011. Clinical and experimental applications of sodium phenylbutyrate. Drugs RD11:227-249. http://dx.doi.org/10.2165 /11591280-000000000-00000.
    • (2011) Drugs , vol.RD11 , pp. 227-249
    • Iannitti, T.1    Palmieri, B.2
  • 34
    • 7944230917 scopus 로고    scopus 로고
    • Could valerian have been the first anticonvulsant?
    • Eadie MJ. 2004. Could valerian have been the first anticonvulsant? Epilepsia 45:1338-1343. http://dx.doi.org/10.1111/j.0013-9580.2004.27904.x.
    • (2004) Epilepsia , vol.45 , pp. 1338-1343
    • Eadie, M.J.1
  • 35
    • 0020045179 scopus 로고
    • New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma
    • Heston L, Rabson M, Brown N, Miller G. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295:160-163. http://dx.doi.org/10.1038/295160a0.
    • (1982) Nature , vol.295 , pp. 160-163
    • Heston, L.1    Rabson, M.2    Brown, N.3    Miller, G.4
  • 36
    • 0013963675 scopus 로고
    • Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji)
    • Epstein MA, Achong BG, Barr YM, Zajac B, Henle G, Henle W. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:547-559.
    • (1966) J. Natl. Cancer Inst. , vol.37 , pp. 547-559
    • Epstein, M.A.1    Achong, B.G.2    Barr, Y.M.3    Zajac, B.4    Henle, G.5    Henle, W.6
  • 37
    • 0029796383 scopus 로고    scopus 로고
    • Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus
    • Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, Cesarman E. 1996. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88:2648-2654.
    • (1996) Blood , vol.88 , pp. 2648-2654
    • Arvanitakis, L.1    Mesri, E.A.2    Nador, R.G.3    Said, J.W.4    Asch, A.S.5    Knowles, D.M.6    Cesarman, E.7
  • 38
    • 0029121668 scopus 로고
    • In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
    • Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. 1995. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708-2714.
    • (1995) Blood , vol.86 , pp. 2708-2714
    • Cesarman, E.1    Moore, P.S.2    Rao, P.H.3    Inghirami, G.4    Knowles, D.M.5    Chang, Y.6
  • 41
    • 0030947010 scopus 로고    scopus 로고
    • Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency
    • Francis AL, Gradoville L, Miller G. 1997. Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J. Virol. 71:3054-3061.
    • (1997) J. Virol. , vol.71 , pp. 3054-3061
    • Francis, A.L.1    Gradoville, L.2    Miller, G.3
  • 42
    • 0032708891 scopus 로고    scopus 로고
    • Role of the Epstein-Barr virus RTA protein in activation of distinct classes of viral lytic cycle genes
    • Ragoczy T, Miller G. 1999. Role of the Epstein-Barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J. Virol. 73:9858-9866.
    • (1999) J. Virol. , vol.73 , pp. 9858-9866
    • Ragoczy, T.1    Miller, G.2
  • 43
    • 0025214570 scopus 로고
    • Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1
    • Flemington E, Speck SH. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
    • (1990) J. Virol. , vol.64 , pp. 1227-1232
    • Flemington, E.1    Speck, S.H.2
  • 44
    • 0031689188 scopus 로고    scopus 로고
    • Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter
    • Liu P, Liu S, Speck SH. 1998. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter. J. Virol. 72:8230-8239.
    • (1998) J. Virol. , vol.72 , pp. 8230-8239
    • Liu, P.1    Liu, S.2    Speck, S.H.3
  • 45
    • 84864388654 scopus 로고    scopus 로고
    • Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus
    • Yu X, McCarthy PJ, Wang Z, Gorlen DA, Mertz JE. 2012. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus. J. Virol. 86:8086-8096. http://dx.doi.org/10.1128 /JVI.00234-12.
    • (2012) J. Virol. , vol.86 , pp. 8086-8096
    • Yu, X.1    McCarthy, P.J.2    Wang, Z.3    Gorlen, D.A.4    Mertz, J.E.5
  • 46
    • 0019202911 scopus 로고
    • Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells
    • Kawanishi M, Ito Y. 1980. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells. Cancer Lett. 11:129-132. http://dx.doi.org/10.1016/0304-3835(80)90103-2.
    • (1980) Cancer Lett. , vol.11 , pp. 129-132
    • Kawanishi, M.1    Ito, Y.2
  • 47
    • 0020315458 scopus 로고
    • Activation of Epstein-Barr virus expression in human-lymphoblastoid P3hr-1 and Raji cells with propionic-acid and with culture fluids of propionic acid-producing anaerobes
    • Kishishita M, Yanase S, Ito Y. 1982. Activation of Epstein-Barr virus expression in human-lymphoblastoid P3hr-1 and Raji cells with propionic-acid and with culture fluids of propionic acid-producing anaerobes. Cancer Lett. 16: 117-120. http://dx.doi.org/10.1016/0304-3835(82)90051-9.
    • (1982) Cancer Lett. , vol.16 , pp. 117-120
    • Kishishita, M.1    Yanase, S.2    Ito, Y.3
  • 48
    • 0021280711 scopus 로고
    • Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation
    • Anisimova E, Prachova K, Roubal J, Vonka V. 1984. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch. Virol. 81:223-237. http://dx.doi.org/10.1007/BF01309995.
    • (1984) Arch. Virol. , vol.81 , pp. 223-237
    • Anisimova, E.1    Prachova, K.2    Roubal, J.3    Vonka, V.4
  • 49
    • 0017864644 scopus 로고
    • The effect of sodium butyrate on histone modification
    • Sealy L, Chalkley R. 1978. The effect of sodium butyrate on histone modification. Cell 14:115-121. http://dx.doi.org/10.1016/0092-8674(78)90306-9.
    • (1978) Cell , vol.14 , pp. 115-121
    • Sealy, L.1    Chalkley, R.2
  • 50
    • 0018371969 scopus 로고
    • Different accessibilities in chromatin to histone acetylase
    • Cousens LS, Gallwitz D, Alberts BM. 1979. Different accessibilities in chromatin to histone acetylase. J. Biol. Chem. 254:1716-1723.
    • (1979) J. Biol. Chem. , vol.254 , pp. 1716-1723
    • Cousens, L.S.1    Gallwitz, D.2    Alberts, B.M.3
  • 51
    • 15844378212 scopus 로고    scopus 로고
    • Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection
    • Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chang Y, Moore P. 1996. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N. Engl. J. Med. 334:1292-1297. http://dx.doi.org/10.1056/NEJM199605163342003.
    • (1996) N. Engl. J. Med. , vol.334 , pp. 1292-1297
    • Miller, G.1    Rigsby, M.O.2    Heston, L.3    Grogan, E.4    Sun, R.5    Metroka, C.6    Levy, J.A.7    Gao, S.J.8    Chang, Y.9    Moore, P.10
  • 52
    • 0035965343 scopus 로고    scopus 로고
    • Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
    • Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276:36734-36741. http://dx.doi.org/10.1074/jbc.M101287200.
    • (2001) J. Biol. Chem. , vol.276 , pp. 36734-36741
    • Phiel, C.J.1    Zhang, F.2    Huang, E.Y.3    Guenther, M.G.4    Lazar, M.A.5    Klein, P.S.6
  • 53
    • 0030741385 scopus 로고    scopus 로고
    • Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors
    • McBain JA, Eastman A, Nobel CS, Mueller GC. 1997. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem. Pharmacol. 53:1357-1368. http://dx.doi.org/10.1016/S0006-2952(96)00904-5.
    • (1997) Biochem. Pharmacol. , vol.53 , pp. 1357-1368
    • McBain, J.A.1    Eastman, A.2    Nobel, C.S.3    Mueller, G.C.4
  • 54
    • 0035173093 scopus 로고    scopus 로고
    • Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus
    • Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE. 2001. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 75:867-877. http: //dx.doi.org/10.1128/JVI.75.2.867-877.2001.
    • (2001) J. Virol. , vol.75 , pp. 867-877
    • Kraus, R.J.1    Mirocha, S.J.2    Stephany, H.M.3    Puchalski, J.R.4    Mertz, J.E.5
  • 55
    • 37849038673 scopus 로고    scopus 로고
    • ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus
    • e194
    • Yu X, Wang Z, Mertz JE. 2007. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog. 3:e194. http://dx.doi.org/10.1371/journal.ppat.0030194.
    • (2007) PLoS Pathog. , vol.3
    • Yu, X.1    Wang, Z.2    Mertz, J.E.3
  • 56
    • 84862646923 scopus 로고    scopus 로고
    • p53 and Sp1 cooperate to regulate the expression of Epstein-Barr viral Zta protein
    • Chua HH, Chiu HY, Lin SJ, Weng PL, Lin JH, Wu SW, Tsai SC, Tsai CH. 2012. p53 and Sp1 cooperate to regulate the expression of Epstein-Barr viral Zta protein. J. Med. Virol. 84:1279-1288. http://dx.doi.org/10.1002/jmv.23316.
    • (2012) J. Med. Virol. , vol.84 , pp. 1279-1288
    • Chua, H.H.1    Chiu, H.Y.2    Lin, S.J.3    Weng, P.L.4    Lin, J.H.5    Wu, S.W.6    Tsai, S.C.7    Tsai, C.H.8
  • 57
    • 79955431211 scopus 로고    scopus 로고
    • The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2-and p53-dependent manner
    • Hagemeier SR, Barlow EA, Kleman AA, Kenney SC. 2011. The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2-and p53-dependent manner. J. Virol. 85:4318-4329. http://dx.doi.org/10.1128/JVI.01856-10.
    • (2011) J. Virol. , vol.85 , pp. 4318-4329
    • Hagemeier, S.R.1    Barlow, E.A.2    Kleman, A.A.3    Kenney, S.C.4
  • 58
    • 84870704593 scopus 로고    scopus 로고
    • The cellular ataxia telangiectasia-mutated kinase promotes Epstein-Barr virus lytic reactivation in response to multiple different types of lytic reactivationinducing stimuli
    • Hagemeier SR, Barlow EA, Meng Q, Kenney SC. 2012. The cellular ataxia telangiectasia-mutated kinase promotes Epstein-Barr virus lytic reactivation in response to multiple different types of lytic reactivationinducing stimuli. J. Virol. 86:13360-13370. http://dx.doi.org/10.1128/JVI.01850-12.
    • (2012) J. Virol. , vol.86 , pp. 13360-13370
    • Hagemeier, S.R.1    Barlow, E.A.2    Meng, Q.3    Kenney, S.C.4
  • 59
    • 47749134215 scopus 로고    scopus 로고
    • Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression
    • Chang SS, Lo YC, Chua HH, Chiu HY, Tsai SC, Chen JY, Lo KW, Tsai CH. 2008. Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J. Virol. 82:7745-7751. http://dx.doi.org/10.1128/JVI.02717-07.
    • (2008) J. Virol. , vol.82 , pp. 7745-7751
    • Chang, S.S.1    Lo, Y.C.2    Chua, H.H.3    Chiu, H.Y.4    Tsai, S.C.5    Chen, J.Y.6    Lo, K.W.7    Tsai, C.H.8
  • 60
    • 67349095745 scopus 로고    scopus 로고
    • Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription
    • Sato Y, Shirata N, Kudoh A, Iwahori S, Nakayama S, Murata T, Isomura H, Nishiyama Y, Tsurumi T. 2009. Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription. Virology 388:204-211. http://dx.doi.org/10.1016/j.virol.2009.03.017.
    • (2009) Virology , vol.388 , pp. 204-211
    • Sato, Y.1    Shirata, N.2    Kudoh, A.3    Iwahori, S.4    Nakayama, S.5    Murata, T.6    Isomura, H.7    Nishiyama, Y.8    Tsurumi, T.9
  • 61
    • 14844336913 scopus 로고    scopus 로고
    • Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phaselike cellular environment
    • Kudoh A, Fujita M, Zhang L, Shirata N, Daikoku T, Sugaya Y, Isomura H, Nishiyama Y, Tsurumi T. 2005. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phaselike cellular environment. J. Biol. Chem. 280:8156-8163. http://dx.doi.org/10.1074/jbc.M411405200.
    • (2005) J. Biol. Chem. , vol.280 , pp. 8156-8163
    • Kudoh, A.1    Fujita, M.2    Zhang, L.3    Shirata, N.4    Daikoku, T.5    Sugaya, Y.6    Isomura, H.7    Nishiyama, Y.8    Tsurumi, T.9
  • 62
    • 84904706095 scopus 로고    scopus 로고
    • Regulation of expression, mode of action and downstream targets of ORF50 protein in KSHV lytic cycle activation
    • Damania B, Pipas JM (ed). Springer-Verlag, New York, NY
    • Chang P-J, Ye J, Miller G. 2009. Regulation of expression, mode of action and downstream targets of ORF50 protein in KSHV lytic cycle activation, p 521-553. In Damania B, Pipas JM (ed), DNA tumor viruses. Springer-Verlag, New York, NY.
    • (2009) DNA tumor viruses , pp. 521-553
    • Chang, P.-J.1    Ye, J.2    Miller, G.3
  • 63
    • 18744390485 scopus 로고    scopus 로고
    • Reactivation of Epstein-Barr virus from latency
    • Amon W, Farrell PJ. 2005. Reactivation of Epstein-Barr virus from latency. Rev. Med. Virol. 15:149-156. http://dx.doi.org/10.1002/rmv.456.
    • (2005) Rev. Med. Virol. , vol.15 , pp. 149-156
    • Amon, W.1    Farrell, P.J.2
  • 64
    • 0033024624 scopus 로고    scopus 로고
    • Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells
    • Bar-Ner M, Thibault A, Tsokos M, Magrath IT, Samid D. 1999. Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells. Clin. Cancer Res. 5:1509-1516.
    • (1999) Clin. Cancer Res. , vol.5 , pp. 1509-1516
    • Bar-Ner, M.1    Thibault, A.2    Tsokos, M.3    Magrath, I.T.4    Samid, D.5
  • 65
    • 0034088092 scopus 로고    scopus 로고
    • A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinaseCmodulator: implications for radiosensitization and EBV-targeted therapy
    • Chung YL, Lee YH, Yen SH, Chi KH. 2000. A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinaseCmodulator: implications for radiosensitization and EBV-targeted therapy. Clin. Cancer Res. 6:1452-1458.
    • (2000) Clin. Cancer Res. , vol.6 , pp. 1452-1458
    • Chung, Y.L.1    Lee, Y.H.2    Yen, S.H.3    Chi, K.H.4
  • 67
    • 76949102343 scopus 로고    scopus 로고
    • Inhibition of the Epstein-Barr virus lytic cycle by moronic acid
    • Chang FR, Hsieh YC, Chang YF, Lee KH, Wu YC, Chang LK. 2010. Inhibition of the Epstein-Barr virus lytic cycle by moronic acid. Antiviral Res. 85:490-495. http://dx.doi.org/10.1016/j.antiviral.2009.12.002.
    • (2010) Antiviral Res. , vol.85 , pp. 490-495
    • Chang, F.R.1    Hsieh, Y.C.2    Chang, Y.F.3    Lee, K.H.4    Wu, Y.C.5    Chang, L.K.6
  • 68
    • 78149454317 scopus 로고    scopus 로고
    • Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle
    • Yiu CY, Chen SY, Chang LK, Chiu YF, Lin TP. 2010. Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle. Molecules 15:7115-7124. http://dx.doi.org/10.3390/molecules15107115.
    • (2010) Molecules , vol.15 , pp. 7115-7124
    • Yiu, C.Y.1    Chen, S.Y.2    Chang, L.K.3    Chiu, Y.F.4    Lin, T.P.5
  • 69
    • 0142060892 scopus 로고    scopus 로고
    • Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency
    • Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM. 2003. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 77: 11425-11435. http://dx.doi.org/10.1128/JVI.77.21.11425-11435.2003.
    • (2003) J. Virol. , vol.77 , pp. 11425-11435
    • Lu, F.1    Zhou, J.2    Wiedmer, A.3    Madden, K.4    Yuan, Y.5    Lieberman, P.M.6
  • 70
    • 33646723291 scopus 로고    scopus 로고
    • Acetylation of the latencyassociated nuclear antigen regulates repression of Kaposi's sarcomaassociated herpesvirus lytic transcription
    • Lu F, Day L, Gao SJ, Lieberman PM. 2006. Acetylation of the latencyassociated nuclear antigen regulates repression of Kaposi's sarcomaassociated herpesvirus lytic transcription. J. Virol. 80:5273-5282. http: //dx.doi.org/10.1128/JVI.02541-05.
    • (2006) J. Virol. , vol.80 , pp. 5273-5282
    • Lu, F.1    Day, L.2    Gao, S.J.3    Lieberman, P.M.4
  • 71
    • 84866183349 scopus 로고    scopus 로고
    • Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency
    • Chen HS, Wikramasinghe P, Showe L, Lieberman PM. 2012. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. J. Virol. 86:9454-9464. http://dx.doi.org/10.1128/JVI.00787-12.
    • (2012) J. Virol. , vol.86 , pp. 9454-9464
    • Chen, H.S.1    Wikramasinghe, P.2    Showe, L.3    Lieberman, P.M.4
  • 72
    • 0034667777 scopus 로고    scopus 로고
    • Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation
    • Chang LK, Liu ST. 2000. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res. 28:3918-3925. http://dx.doi.org/10.1093/nar/28.20.3918.
    • (2000) Nucleic Acids Res. , vol.28 , pp. 3918-3925
    • Chang, L.K.1    Liu, S.T.2
  • 73
    • 0033987840 scopus 로고    scopus 로고
    • Histone acetylation and reactivation of Epstein-Barr virus from latency
    • Jenkins PJ, Binne UK, Farrell PJ. 2000. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74:710-720. http://dx.doi.org/10.1128/JVI.74.2.710-720.2000.
    • (2000) J. Virol. , vol.74 , pp. 710-720
    • Jenkins, P.J.1    Binne, U.K.2    Farrell, P.J.3
  • 74
    • 84861313347 scopus 로고    scopus 로고
    • Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells
    • Murata T, Kondo Y, Sugimoto A, Kawashima D, Saito S, Isomura H, Kanda T, Tsurumi T. 2012. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells. J. Virol. 86:4752-4761. http://dx.doi.org/10.1128/JVI.06768-11.
    • (2012) J. Virol. , vol.86 , pp. 4752-4761
    • Murata, T.1    Kondo, Y.2    Sugimoto, A.3    Kawashima, D.4    Saito, S.5    Isomura, H.6    Kanda, T.7    Tsurumi, T.8
  • 75
    • 84857078927 scopus 로고    scopus 로고
    • Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome
    • Ramasubramanyan S, Osborn K, Flower K, Sinclair AJ. 2012. Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome. J. Virol. 86:1809-1819. http://dx.doi.org/10.1128/JVI.06334-11.
    • (2012) J. Virol. , vol.86 , pp. 1809-1819
    • Ramasubramanyan, S.1    Osborn, K.2    Flower, K.3    Sinclair, A.J.4
  • 76
    • 0025941281 scopus 로고
    • Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria
    • Asai S, Nakamura Y, Yamamura M, Ikezawa H, Namikawa I. 1991. Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria. Arch. Virol. 119:291-296. http://dx.doi.org/10.1007/BF01310678.
    • (1991) Arch. Virol. , vol.119 , pp. 291-296
    • Asai, S.1    Nakamura, Y.2    Yamamura, M.3    Ikezawa, H.4    Namikawa, I.5
  • 77
    • 34249780138 scopus 로고    scopus 로고
    • Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus
    • Morris TL, Arnold RR, Webster-Cyriaque J. 2007. Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus. J. Virol. 81:6032-6042. http://dx.doi.org/10.1128/JVI.02504-06.
    • (2007) J. Virol. , vol.81 , pp. 6032-6042
    • Morris, T.L.1    Arnold, R.R.2    Webster-Cyriaque, J.3
  • 78
    • 0019427243 scopus 로고
    • Butyrate and propionate-important components of toxic dental plaque extracts
    • Singer RE, Buckner BA. 1981. Butyrate and propionate-important components of toxic dental plaque extracts. Infect. Immun. 32:458-463.
    • (1981) Infect. Immun. , vol.32 , pp. 458-463
    • Singer, R.E.1    Buckner, B.A.2
  • 79
    • 0024224736 scopus 로고
    • Composition of pooled resting plaque fluid from caries-free and caries-susceptible individuals
    • Margolis HC, Duckworth JH, Moreno EC. 1988. Composition of pooled resting plaque fluid from caries-free and caries-susceptible individuals. J. Dent. Res. 67:1468-1475. http://dx.doi.org/10.1177/0022 0345880670120601.
    • (1988) J. Dent. Res. , vol.67 , pp. 1468-1475
    • Margolis, H.C.1    Duckworth, J.H.2    Moreno, E.C.3
  • 80
    • 0033125193 scopus 로고    scopus 로고
    • Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria
    • Contreras A, Umeda M, Chen C, Bakker I, Morrison JL, Slots J. 1999. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. J. Periodontol. 70:478-484. http://dx.doi.org/10.1902/jop.1999.70.5.478.
    • (1999) J. Periodontol. , vol.70 , pp. 478-484
    • Contreras, A.1    Umeda, M.2    Chen, C.3    Bakker, I.4    Morrison, J.L.5    Slots, J.6
  • 81
    • 0034296783 scopus 로고    scopus 로고
    • Herpesviruses 6, 7 and 8 in HIV-and non-HIV-associated periodontitis
    • Mardirossian A, Contreras A, Navazesh M, Nowzari H, Slots J. 2000. Herpesviruses 6, 7 and 8 in HIV-and non-HIV-associated periodontitis. J. Periodontal Res. 35:278-284. http://dx.doi.org/10.1034/j.1600-0765.2000.035005278.x.
    • (2000) J. Periodontal Res. , vol.35 , pp. 278-284
    • Mardirossian, A.1    Contreras, A.2    Navazesh, M.3    Nowzari, H.4    Slots, J.5
  • 82
    • 77649274673 scopus 로고    scopus 로고
    • Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome
    • Nagao K, Yanagita T. 2010. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol. Res. 61:208-212. http://dx.doi.org/10.1016/j.phrs.2009.11.007.
    • (2010) Pharmacol. Res. , vol.61 , pp. 208-212
    • Nagao, K.1    Yanagita, T.2
  • 83
    • 80052492765 scopus 로고    scopus 로고
    • Dietary therapies for epilepsy: future research
    • Kessler SK, Neal EG, Camfield CS, Kossoff EH. 2011. Dietary therapies for epilepsy: future research. Epilepsy Behav. 22:17-22. http://dx.doi.org /10.1016/j.yebeh.2011.02.018.
    • (2011) Epilepsy Behav. , vol.22 , pp. 17-22
    • Kessler, S.K.1    Neal, E.G.2    Camfield, C.S.3    Kossoff, E.H.4
  • 84
    • 0020061350 scopus 로고
    • Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet
    • Haidukewych D, Forsythe WI, Sills M. 1982. Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet. Clin. Chem. 28:642-645.
    • (1982) Clin. Chem. , vol.28 , pp. 642-645
    • Haidukewych, D.1    Forsythe, W.I.2    Sills, M.3
  • 85
    • 33749031579 scopus 로고    scopus 로고
    • Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression
    • Feng WH, Kenney SC. 2006. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression. Cancer Res. 66:8762-8769. http://dx.doi.org/10.1158/0008-5472.CAN-06-1006.
    • (2006) Cancer Res. , vol.66 , pp. 8762-8769
    • Feng, W.H.1    Kenney, S.C.2
  • 87
    • 35649007224 scopus 로고    scopus 로고
    • Pilot study of sodium phenylbutyrate as adjuvant in cyclophosphamide-resistant endemic Burkitt's lymphoma
    • Phillips JA, Griffin BE. 2007. Pilot study of sodium phenylbutyrate as adjuvant in cyclophosphamide-resistant endemic Burkitt's lymphoma. Trans. R. Soc. Trop. Med. Hyg. 101:1265-1269. http://dx.doi.org/10.1016 /j.trstmh.2007.06.020.
    • (2007) Trans. R. Soc. Trop. Med. Hyg. , vol.101 , pp. 1265-1269
    • Phillips, J.A.1    Griffin, B.E.2
  • 88
    • 77249177223 scopus 로고    scopus 로고
    • Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity
    • e169-e174
    • Jones K, Nourse J, Corbett G, Gandhi MK. 2010. Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity. Int. J. Lab. Hematol. 32:e169-e174. http://dx.doi.org/10.1111/j.1751-553X.2008.01130.x.
    • (2010) Int. J. Lab. Hematol. , vol.32
    • Jones, K.1    Nourse, J.2    Corbett, G.3    Gandhi, M.K.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.